JOHN MARAGANORE

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Bruce Jacobs, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by JOHN MARAGANORE:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ALNYLAM PHARMACEUTICALS, INC. Chief Executive Officer, Director Common Stock 228K $42.2M $185.32 22 Dec 2021 Direct
PROKIDNEY CORP. Director Common Units in ProKidney LP 614K $921K $1.50 11 Jul 2022 Direct
AGIOS PHARMACEUTICALS, INC. Director Common stock 28.5K $617K $21.64 20 Sep 2022 Direct
ALNYLAM PHARMACEUTICALS, INC. Chief Executive Officer, Director Common Stock 3.13K $581K $185.32 21 Dec 2021 by Managed Account
Beam Therapeutics Inc. Director Stock Option (Right to Buy) 33.7K $564K $24.40 04 Jun 2025 Direct
AGIOS PHARMACEUTICALS, INC. Director Restricted stock unit 4.98K $123K $24.79 21 Jun 2022 Direct
PROKIDNEY CORP. Director Class B Ordinary Shares 614K 11 Jul 2022 Direct
ALNYLAM PHARMACEUTICALS, INC. Chief Executive Officer, Director Stock Option (right to buy) 51.7K 10 Dec 2021 Direct
PROKIDNEY CORP. Director Director stock option (right to buy) 48.1K 29 Jun 2023 Direct
AGIOS PHARMACEUTICALS, INC. Director Stock options (right to buy) 29.3K 21 Jun 2022 Direct
Rapport Therapeutics, Inc. Director Stock Option (Right to Buy) 21.9K 17 Jun 2025 Direct
Kymera Therapeutics, Inc. Director Stock Option (Right to Buy) 16K 25 Jun 2025 Direct
PROKIDNEY CORP. Director No securities owned. 0 11 Jul 2022 Direct

Insider Reports Filed by JOHN MARAGANORE

Symbol Company Period Transactions Value $ Form Type Role Filing Time
KYMR Kymera Therapeutics, Inc. 25 Jun 2025 1 $0 4 Director 26 Jun 2025, 21:00
RAPP Rapport Therapeutics, Inc. 17 Jun 2025 1 $0 4 Director 18 Jun 2025, 16:15
BEAM Beam Therapeutics Inc. 04 Jun 2025 1 $0 4 Director 06 Jun 2025, 16:05
KYMR Kymera Therapeutics, Inc. 18 Jun 2024 1 $0 4 Director 20 Jun 2024, 17:00
RAPP Rapport Therapeutics, Inc. 06 Jun 2024 0 $0 3 Director 06 Jun 2024, 18:56
BEAM Beam Therapeutics Inc. 05 Jun 2024 1 $0 4 Director 07 Jun 2024, 16:47
PROK PROKIDNEY CORP. 29 Jun 2023 1 $0 4 Director 03 Jul 2023, 09:17
KYMR Kymera Therapeutics, Inc. 15 Jun 2023 1 $0 4 Director 20 Jun 2023, 16:15
BEAM Beam Therapeutics Inc. 06 Jun 2023 1 $0 4 Director 08 Jun 2023, 16:47
AGIO AGIOS PHARMACEUTICALS, INC. 31 Dec 2022 1 $0 5 Director 03 Feb 2023, 15:06
BEAM Beam Therapeutics Inc. 01 Sep 2022 1 $0 4 Director 02 Sep 2022, 16:05
PROK PROKIDNEY CORP. 11 Jul 2022 2 $0 4 Director 13 Jul 2022, 21:29
PROK PROKIDNEY CORP. 11 Jul 2022 0 $0 3 Director 13 Jul 2022, 21:18
AGIO AGIOS PHARMACEUTICALS, INC. 21 Jun 2022 2 $0 4 Director 23 Jun 2022, 16:11
AGIO AGIOS PHARMACEUTICALS, INC. 20 May 2022 2 $0 4 Director 24 May 2022, 16:10
KYMR Kymera Therapeutics, Inc. 18 Jan 2022 1 $0 4 Director 19 Jan 2022, 16:35
KYMR Kymera Therapeutics, Inc. 17 Jan 2022 0 $0 3 Director 19 Jan 2022, 16:30
ALNY ALNYLAM PHARMACEUTICALS, INC. 21 Dec 2021 4 -$1.25M 4 Chief Executive Officer, Director 23 Dec 2021, 16:00
ALNY ALNYLAM PHARMACEUTICALS, INC. 10 Dec 2021 8 $400K 4 Chief Executive Officer, Director 14 Dec 2021, 15:05
ALNY ALNYLAM PHARMACEUTICALS, INC. 12 Nov 2021 7 -$5.59M 4 Chief Executive Officer, Director 12 Nov 2021, 16:52
BEAM Beam Therapeutics Inc. 05 Nov 2021 1 $0 4 Director 08 Nov 2021, 19:05
BEAM Beam Therapeutics Inc. 05 Nov 2021 0 $0 3 Director 08 Nov 2021, 19:00
ALNY ALNYLAM PHARMACEUTICALS, INC. 13 Aug 2021 7 -$6.55M 4 Chief Executive Officer, Director 16 Aug 2021, 16:38
AGIO AGIOS PHARMACEUTICALS, INC. 28 May 2021 3 $0 4 Director 02 Jun 2021, 16:09
AGIO AGIOS PHARMACEUTICALS, INC. 20 May 2021 2 $0 4 Director 24 May 2021, 16:45
ALNY ALNYLAM PHARMACEUTICALS, INC. 13 May 2021 9 -$4.2M 4 Chief Executive Officer, Director 17 May 2021, 19:25